Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Gufic BioSciences Ltd
BSE: 509079 | NSE: GUFICBIO | ISIN: INE742B01025
Market Cap: [Rs.Cr.] 48 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Discuss this stock
Corporate Announcements
May 22, 2013
Gufic Biosciences - Board to consider Dividend
Gufic Biosciences Limited - Board meeting Cancelled
Nov 05, 2012
Gufic Biosciences Limited - Updates
Oct 04, 2012
Gufic Biosciences' board approves conversion of unsecured loans into equity
Gufic Biosciences Limited - Outcome of Board Meeting
Sep 25, 2012
Gufic Biosciences to hold board meeting
Aug 09, 2012
Gufic Biosciences Limited - Disclosure under SEBI Takeover Regulations
Jul 11, 2012
Gufic Biosciences Limited - Dividend
Gufic Biosciences recommends dividend
Jul 03, 2012
Gufic Biosciences to consider Dividend
Jun 06, 2012
Gufic Biosciences to consider dividend
Sep 02, 2011
Gufic Biosciences declares dividend
Gufic Biosciences Limited - Dividend
Aug 31, 2011
Gufic Biosciences adjourns board meeting
Aug 24, 2011
Gufic Biosciences to consider dividend
Aug 31, 2010
Gufic Biosciences recommends dividend
Gufic Biosciences Limited - Dividend
Apr 04, 2008
Gufic Biosciences Limited - Outcome of AGM
Mar 26, 2008
Gufic Biosciences Limited - Results of Postal Ballot
Mar 10, 2008
Gufic Biosciences Limited - Payment of Dividend
Prev
Next
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
22-May-13
Gufic Biosciences - Board to consider Dividend
23-Feb-13
Gufic BioSciences net profit rises 117.95% in the December 2012 quarter
20-Nov-12
Gufic BioSciences net profit rises 89.36% in the September 2012 quarter
03-Oct-12
Gufic Biosciences' board approves conversion of unsecured loans into equity
24-Sep-12
Gufic Biosciences to hold board meeting
10-Jul-12
Gufic Biosciences recommends dividend
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds.
100,416.95
69.76
12.38
27.45
26.1
27.0
0.01
Dr Reddy's Labs
35,071.23
27.71
4.61
18.79
14.3
16.6
0.25
Cipla
32,778.39
21.41
4.35
14.11
15.9
19.8
0.03
Ranbaxy Labs.
16,513.59
0.00
8.60
72.87
0.0
0.0
2.38
Cadila Health.
16,249.19
39.39
6.37
18.45
28.4
24.2
0.40
Glenmark Pharma.
14,932.01
38.68
5.92
23.94
12.7
11.7
0.39
Wockhardt
13,475.05
80.27
111.99
12.82
237.0
30.3
2.09
Piramal Enterp.
9,623.98
0.00
0.91
23.66
0.8
2.1
0.07
Ipca Labs.
7,202.23
21.66
5.71
10.09
24.2
23.7
0.49
Torrent Pharma.
6,125.22
11.46
4.70
11.66
29.6
25.5
0.48
Biocon
5,488.00
19.14
2.49
12.20
12.6
13.6
0.08
Strides Arcolab
5,270.21
35.93
3.84
46.94
7.3
8.9
0.56
Aurobindo Pharma
4,995.54
11.88
2.00
22.89
10.7
8.8
1.01
Mylan Lab.
3,273.19
6.80
1.77
0.00
26.9
26.1
0.59
Alembic Pharma
2,222.42
14.12
4.83
5.60
39.5
27.7
1.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Jayesh P Choksi , Chairman & Managing Director
Pranav J Choksi , Executive Director
M G Dhapalapur , Executive Director
Sharat S Gandhi , Director
Company Head Office / Quarters:
2nd Floor Building A Moti Baug,
118/119 S V Road Andheri(W),
Mumbai,
Maharashtra-400058
Phone :
Fax :
E-mail :
Web :
http://
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
No result today
View full month Results calendar